Biotech · Private company
NantPharma, LLC
Track this companyFree. Adds NantPharma, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- AMG 337Phase 2 · Clear Cell SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- AMG 337Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Avastin Injectable ProductPhase 2 · Pancreatic Adenocarcinoma MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- Eloxatin Injectable ProductPhase 2 · Pancreatic Adenocarcinoma MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- Fluorouracil Injectable ProductPhase 2 · Pancreatic Adenocarcinoma MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- Leucovorin Calcium InjectionPhase 2 · Pancreatic Adenocarcinoma MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- NANT-008Phase 2 · Pancreatic Adenocarcinoma MetastaticClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell SarcomaPHASE2 · TERMINATED · started Aug 29, 2018ClinicalTrials.gov NCT03132155 · fetched Nov 12, 2026
- QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid TumorsPHASE2 · WITHDRAWN · started May 2, 2018ClinicalTrials.gov NCT03147976 · fetched Nov 12, 2026
- QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic CancerPHASE1_PHASE2 · WITHDRAWN · started Feb 27, 2018ClinicalTrials.gov NCT03127124 · fetched Nov 12, 2026